Assays for the Evaluation of the Immune Response to Marburg and Ebola Sudan Vaccination—Filovirus Animal Nonclinical Group Anti-Marburg Virus Glycoprotein Immunoglobulin G Enzyme-Linked Immunosorbent Assay and a Pseudovirion Neutralization Assay

Since the discovery of the Marburg virus (MARV) in 1967 and Ebola virus (EBOV) in 1976, there have been over 40 reported outbreaks of filovirus disease with case fatality rates greater than 50%. This underscores the need for efficacious vaccines against these highly pathogenic filoviruses. Due to th...

Descripción completa

Detalles Bibliográficos
Autores principales: Rudge, Thomas L., Machesky, Nicholas J., Sankovich, Karen A., Lemmon, Erin E., Badorrek, Christopher S., Overman, Rachel, Niemuth, Nancy A., Anderson, Michael S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413256/
https://www.ncbi.nlm.nih.gov/pubmed/36016099
http://dx.doi.org/10.3390/vaccines10081211

Ejemplares similares

Ejemplares similares